Protocol for a randomized study assessing the feasibility of home-based albuminuria screening among the general population: The THOMAS study
Dominique van Mil(University Medical Center Groningen), Ron T. Gansevoort, Hiddo J.L. Heerspink(University Medical Center Groningen), Marc Thelen(Radboud University Nijmegen), Marc H. Hemmelder(Nefrovisie), Ronald W. van Etten(Amphia Ziekenhuis), A Dorgelo(Nierstichting), Birgitte Evers-Roeten, Hanne de Vries(Jeroen Bosch Ziekenhuis), Lyanne M. Kieneker(University Medical Center Groningen)
Cited by 7
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
|Kidney International|2010|2.3k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990